Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach
Bisphosphonates are commonly prescribed to inhibit bone loss in patients with osteoporosis, as well as osteopenia, cancer, and Paget's disease of the bone. Recently, scientific literature has addressed a possible relationship between bisphosphonates and osteonecrosis of the jaw (ONJ). It is imp...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Milano :
Springer Milan,
2012.
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
